Short answer · Medically reviewed summary · Last updated: 2026-04-07
The estimated global prevalence of Keratoconus is approximately 1 in 375 to 1 in 2,000 individuals, though these figures vary significantly by geography and diagnostic criteria. While often classified as a rare condition, recent studies suggest Keratoconus may be more common than historically reported due to improved corneal imaging technology that identifies subclinical cases. What is the global prevalence and incidence of Keratoconus? The prevalence of Keratoconus is difficult to quantify precisely because clinical definitions and diagnostic thresholds for the disease have evolved over time.
1 people with Keratoconus have shared their first-person experience on this question at DiseaseMaps.
The estimated global prevalence of Keratoconus is approximately 1 in 375 to 1 in 2,000 individuals, though these figures vary significantly by geography and diagnostic criteria. While often classified as a rare condition, recent studies suggest Keratoconus may be more common than historically reported due to improved corneal imaging technology that identifies subclinical cases.
The prevalence of Keratoconus is difficult to quantify precisely because clinical definitions and diagnostic thresholds for the disease have evolved over time. While older literature often cited a prevalence of 1 in 2,000, modern meta-analyses suggest the true global prevalence of Keratoconus is closer to 1 in 375. Incidence rates are similarly challenging to track, as many individuals with mild disease remain asymptomatic and undiagnosed for years. Within the DiseaseMaps.org community, 724 people with Keratoconus have connected to share their experiences, reflecting the significant population of patients currently navigating this diagnosis globally.
Research into Keratoconus indicates that the condition affects all ethnic groups, though some studies suggest a higher prevalence in populations of Middle Eastern and South Asian descent. Regarding gender, while historical data often suggested a slight male predominance, many contemporary studies show a more equitable distribution, suggesting that gender-based prevalence differences may be less pronounced than previously thought. The age of onset for Keratoconus typically occurs during puberty or late adolescence, with the disease often progressing until the third or fourth decade of life before stabilizing.
The primary challenge in establishing accurate prevalence data for Keratoconus is the nature of the disease itself. Because early-stage Keratoconus often presents with minimal symptoms, many patients are not diagnosed until the condition has progressed to a point where vision is significantly impacted. Furthermore, diagnostic criteria vary; some clinicians use strict definitions based on corneal topography, while others include "forme fruste" (subclinical) cases. Key factors influencing diagnostic numbers include:
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.